debulking surgery

PROCEDURE4 trials

Sponsors

SWOG Cancer Research Network, Seoul National University Hospital, Fudan University, Uppsala University

Conditions

Fallopian Tube CancerLymph Node MetastasesOvarian CancerOvarian Cancer Stage IVPancreatic Neuroendocrine TumorPeritoneal Cavity Cancer

Phase 2

S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer

CompletedNCT00008138

SWOG Cancer Research NetworkFallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer

Start: 2001-03-31End: 2009-11-30Updated: 2016-01-08

Phase 3

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

Fudan UniversityOvarian Cancer

Start: 2021-07-16End: 2023-12-31Target: 200Updated: 2022-05-12

Unknown Phase

Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy

CompletedNCT05005650

Seoul National University HospitalLymph Node Metastases, Ovarian Cancer Stage IV

Start: 2021-06-01End: 2021-12-31Updated: 2023-06-26

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not

RecruitingNCT07273409

Uppsala UniversityPancreatic Neuroendocrine Tumor

Start: 2026-01-09End: 2033-05-31Target: 200Updated: 2026-01-22

Related Papers

Impact of supradiaphragmatic lymphadenectomy on the survival of patients in stage IVB ovarian cancer with thoracic lymph node metastasis

Frontiers in Oncology2023-08-103 citations